跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Namn
首页
药物
Namn
Experimental
Small Molecule
Namn
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
11
H
14
NO
9
P
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations
US 12485134 B2
申请人: CHROMADEX INC
优先权: 2019
CN
US
WO
4 件公开
COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS
EP 3820433 A1
申请人: NUCHIDO LTD
优先权: 2018
CN
EP
US
3 件公开
NAD+ PRECURSOR SELECTED FROM NMN, NAAD, NAMN, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE IN TREATING A SIDE EFFECT OF CHEMOTHERAPY AND/OR RADIOTHERAPY IN A SUBJECT
EP 3068364 B1
申请人: METRO BIOTECH NSW PTY LTD
优先权: 2013
EP
RESETTING BIOLOGICAL PATHWAYS FOR DEFENDING AGAINST AND REPAIRING DETERIORATION FROM HUMAN AGING
CN 108290059 A
申请人: HUIZENGA JOEL
优先权: 2015
CN
Compounds based on nicotinate and nicotinamide riboside and derivatives thereof
CN 118613472 A
申请人: NEW FRONTIER BIO INC
优先权: 2022
CN
Nicotinic acid mononucleotide microcapsule as well as preparation method and application thereof
CN 118453532 A
申请人: ZHONGKE SAILIFU PARTICLE MEDICINE SHENZHEN CO LTD
优先权: 2024
CN
药物
反馈